Both Republican and Democratic senators have criticized moves by drug makers to extend the life of their monopolies on sales. But action on high drug prices, a major concern for consumers, has been so far negligible in this Congress.
Both Republican and Democratic senators have criticized moves by drug makers to extend the life of their monopolies on sales. But action on high drug prices, a major concern for consumers, has been so far negligible in this Congress.